Citation Impact
Citing Papers
Species Interactions in a Parasite Community Drive Infection Risk in a Wildlife Population
2010 StandoutScience
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
2005 Standout
Immune Control of Tuberculosis by IFN-γ-Inducible LRG-47
2003 StandoutScience
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
2004 StandoutScience
Cost-effectiveness of community health workers in tuberculosis control in Bangladesh.
2002
The decline of tuberculosis epidemics under chemotherapy: a case study in Morocco.
2007
Risk of tuberculosis infection and disease associated with work in health care settings.
2007
Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study
2008 Standout
In silico prediction of protein-protein interactions in human macrophages
2014 Standout
Global Investments In TB Control: Economic Benefits
2009
Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus
1992
Pilon: An Integrated Tool for Comprehensive Microbial Variant Detection and Genome Assembly Improvement
2014 Standout
Secretion of interleukin‐8 following phagocytosis of Mycobacterium tuberculosis by human monocyte cell lines
1992
Syndemics and the biosocial conception of health
2017 Standout
Facing the Crisis: Improving the Diagnosis of Tuberculosis in the HIV Era
2007
Treatment of Active Tuberculosis in HIV‐Coinfected Patients: A Systematic Review and Meta‐Analysis
2010
Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa
2007
Tuberculosis
2011
Pleural tuberculosis in Harare, Zimbabwe: the relationship between human immunodeficiency virus, CD4 lymphocyte count, granuloma formation and disseminated disease
1998
Clinical and Radiographic Factors Do Not Accurately Diagnose Smear-Negative Tuberculosis in HIV-infected Inpatients in Uganda: A Cross-Sectional Study
2010
Pneumocystis carinii Pneumonia: An Uncommon Cause of Death in African Patients with Acquired Immunodeficiency Syndrome
1992
Early Immunologic Failure is Associated With Early Mortality Among Advanced HIV–Infected Adults Initiating Antiretroviral Therapy With Active Tuberculosis
2013 StandoutNobel
Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma.
1998
The burden of non-communicable diseases in South Africa
2009 Standout
Six-month supervised intermittent tuberculosis therapy in Haitian patients with and without HIV infection.
1996
Cost effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries
1991
Pulmonary Tuberculosis in HIV-Infected Patients in Zaire — A Controlled Trial of Treatment for Either 6 or 12 Months
1995
IS6110 restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, South India
1995
Tuberculosis Infection Control in Resource‐Limited Settings in the Era of Expanding HIV Care and Treatment
2007
The Detection of Airborne Transmission of Tuberculosis from HIV-Infected Patients, Using an In Vivo Air Sampling Model
2007
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
2008 Standout
Private practitioners and public health: weak links in tuberculosis control
2001
Diagnosis of tuberculosis in South African children with a T cell-based assay: a prospective cohort study
2004
Antibacterial resistance worldwide: causes, challenges and responses
2004 Standout
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1999 Standout
The HIV-associated tuberculosis epidemic—when will we act?
2010
Clinical and Laboratory Markers of Hypersensitivity to Trimethoprim-Sulfamethoxazole in Patients with Pneumocystis carinii Pneumonia and AIDS
1993
Global Burden of Tuberculosis
1999 Standout
Causes of death in hospitalized adults with a premortem diagnosis of tuberculosis: an autopsy study
2007
Impact of HIV Infection on the Epidemiology of Tuberculosis in a Peri-Urban Community in South Africa: The Need for Age-Specific Interventions
2006
Epidemiology of HIV-associated tuberculosis
2009
M. tuberculosis and M. leprae Translocate from the Phagolysosome to the Cytosol in Myeloid Cells
2007 Standout
Mycobacterium tuberculosis: here today, and here tomorrow
2001
Pharmacokinetics of Antimycobacterial Drugs in Patients with Tuberculosis, AIDS, and Diarrhea
1997
Tuberculosis control and elimination 2010–50: cure, care, and social development
2010 Standout
Macrophage migration inhibitory factor: a regulator of innate immunity
2003 Standout
Prospects for worldwide tuberculosis control under the WHO DOTS strategy
1998
The Mycobacterium tuberculosis Virulence Factor Trehalose Dimycolate Imparts Desiccation Resistance to Model Mycobacterial Membranes
2008 StandoutNobel
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa
2006 Standout
Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis
2010
Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis
1995 Standout
Encompassing treatment with prevention: the path for a lasting control of tuberculosis
1999
Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals
2020 StandoutNature
Has the DOTS Strategy Improved Case Finding or Treatment Success? An Empirical Assessment
2008
Tuberculosis Serodiagnosis in a Predominantly HIV-Infected Population of Hospitalized Patients with Cough, Botswana, 2002
2004
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
Sarcoidosis
1997 Standout
Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis
2008
Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment
2006
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
2010 Standout
Autophagy Is a Defense Mechanism Inhibiting BCG and Mycobacterium tuberculosis Survival in Infected Macrophages
2004 Standout
Sex differences in immune responses
2016 Standout
Analysis of the Population Structure of Mycobacterium tuberculosis in Ethiopia, Tunisia, and the Netherlands: Usefulness of DNA Typing for Global Tuberculosis Epidemiology
1995
Treatment of Multidrug-Resistant Tuberculosis
1993
Opportunities and Challenges for HIV Care in Overlapping HIV and TB Epidemics
2008
Prognostic Value of Bronchoalveolar Lavage Lymphocyte Count in Recently Diagnosed Pulmonary Sarcoidosis
1991
Microfluidic diagnostic technologies for global public health
2006 StandoutNature
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation
2017 StandoutNobel
Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes
2007
A marker for Stevens–Johnson syndrome
2004 StandoutNature
From magic bullets back to the Magic Mountain: the rise of extensively drug-resistant tuberculosis
2007
Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis
2010 Standout
Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm
2006 Standout
Maternal mortality: who, when, where, and why
2006 Standout
Tuberculosis and HIV infection in sub-Saharan Africa
1992
Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infection
2006
The Growing Burden of Tuberculosis
2003 Standout
Poverty and infection in the developing world: Healthcare-related infections and infection control in the tropics
2007
Multidrug-resistant tuberculosis at an HIV testing center in Haiti
2006
A study of maternal mortality at the University Teaching Hospital, Lusaka, Zambia: the emergence of tuberculosis as a major non-obstetric cause of maternal death.
1999
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.
1993 Standout
HIV-associated tuberculosis in developing countries: clinical features, diagnosis, and treatment.
1992
Extensively Drug-Resistant Tuberculosis: A New Face to an Old Pathogen
2009
Synthetic Trehalose Glycolipids Confer Desiccation Resistance to Supported Lipid Monolayers
2009 StandoutNobel
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Global trends in antimicrobial use in food animals
2015 Standout
Rv2131c fromMycobacterium tuberculosisIs a CysQ 3′-Phosphoadenosine-5′-phosphatase
2008 StandoutNobel
Risk factors for acquired multidrug-resistant tuberculosis
2003
Active case finding of tuberculosis: historical perspective and future prospects.
2005
Interventions to reduce tuberculosis mortality and transmission in low- and middle-income countries.
2002
Epidemiologic basis of tuberculosis control
1999
1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults
1993 Standout
Visualization of mycobacterial membrane dynamics in live cells
2017 StandoutNobel
Reduced Antituberculosis Drug Concentrations in HIV-Infected Patients Who Are Men or Have Low Weight: Implications for International Dosing Guidelines
2012
Tuberculosis: Commentary on a Reemergent Killer
1992 StandoutScience
MmpL8 is required for sulfolipid-1 biosynthesis and Mycobacterium tuberculosis virulence
2003 StandoutNobel
Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa
2001
Subcellular Partitioning and Intramacrophage Selectivity of Antimicrobial Compounds against Mycobacterium tuberculosis
2017 StandoutNobel
Economic benefit of Tuberculosis control
2007
Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic.
1995
How sex and age affect immune responses, susceptibility to infections, and response to vaccination
2015
Pleural Effusion
2002 Standout
Upregulation of the Phthiocerol Dimycocerosate Biosynthetic Pathway by Rifampin-Resistant,rpoBMutant Mycobacterium tuberculosis
2012 StandoutNobel
Emerging Targets in Photopharmacology
2016 StandoutNobel
National survey of tuberculosis prevalence in Viet Nam
2010
Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination
1997 Standout
Acute Modulation of Mycobacterial Cell Envelope Biogenesis by Front‐Line Tuberculosis Drugs
2018 StandoutNobel
Effects of Human Immunodeficiency Virus Infection on Recurrence of Tuberculosis after Rifampin-Based Treatment: An Analytical Review
2003
Cutaneous Drug Reactions
2001
Disseminated tuberculosis in interferon gamma gene-disrupted mice.
1993 Standout
Works of P Nunn being referenced
Tuberculosis care in community care organizations in sub-Saharan Africa: practice and potential.
1997
Can we get more HIV-positive tuberculosis patients on antiretroviral treatment in a rural district of Malawi?
2005
Impact of HIV on tuberculosis in Zambia: a cross sectional study.
1990
Treatment outcome of an unselected cohort of tuberculosis patients in relation to human immunodeficiency virus serostatus in Zomba hospital, Malawi
1998
Cohort study of HIV-positive and HIV-negative tuberculosis, Nairobi, Kenya: comparison of bacteriological results
1992
Increased recurrence of tuberculosis in HIV-1-infected patients in Kenya
1993
Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis
1991
Tuberculosis in a prison population in Malawi
1997
Tropical respiratory medicine. 2. Impact of human immunodeficiency virus on tuberculosis in developing countries.
1994
Delays in diagnosis and treatment of smear-positive tuberculosis and the incidence of tuberculosis in hospital nurses in Blantyre, Malawi
1997
The effect of human immunodeficiency virus type-1 on the infectiousness of tuberculosis
1994
Screening pulmonary tuberculosis suspects in Malawi: testing different strategies
1997
Recurrence of HIV-related tuberculosis in an endemic area may be due to relapse or reinfection
1994
Surveillance of resistance to antituberculosis drugs in developing countries
1994
Comparison of intermittent ethambutol with rifampicin-based regimens in HIV-infected adults with PTB, Kampala.
2006
Practical and affordable measures for the protection of health care workers from tuberculosis in low-income countries.
1997
Drug-resistant tuberculosis and HIV in Ukraine: a threatening convergence of two epidemics?
2008
An approach to the problems of diagnosing and treating adult smear-negative pulmonary tuberculosis in high-HIV-prevalence settings in sub-Saharan Africa.
1998
The impact of human immunodeficiency virus on presentation and diagnosis of tuberculosis in a cohort study in Zambia.
1993
A review of sex differences in the epidemiology of tuberculosis.
1998
WHO clinical staging of HIV infection and disease, tuberculosis and eligibility for antiretroviral treatment: relationship to CD4 lymphocyte counts.
2005
Tuberculosis and HIV: current status in Africa.
1997
Gender and tuberculosis: a comparison of prevalence surveys with notification data to explore sex differences in case detection.
2000
Tuberculosis patients and practitioners in private clinics in India.
1998
Long-term outcome in patients registered with tuberculosis in Zomba, Malawi: mortality at 7 years according to initial HIV status and type of TB.
2004
Efficacy of an unsupervised ambulatory treatment regimen for smear-negative pulmonary tuberculosis and tuberculous pleural effusion in Malawi.
1999
Commentary: making tuberculosis treatment available for all.
1998
Pulmonary sarcoidosis: alterations in bronchoalveolar lymphocytes and T cell subsets.
1985
Global monitoring of collaborative TB-HIV activities.
2008